Patent classifications
C07C307/10
Sulfonylaminobenzamide compounds as anthelmintics
The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates. ##STR00001##
COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
PROCESSES AND INTERMEDIATES FOR MAKING SWEET TASTE ENHANCERS
The present invention includes methods/processes and intermediates for preparing compounds having structural Formula (XI):
##STR00001## wherein Y is C.sub.1-C.sub.12 alkylene or C.sub.1-C.sub.12 alkenylene; and R.sup.8 and R.sup.12 are independently C.sub.1-C.sub.12 alkyl.
PROCESSES AND INTERMEDIATES FOR MAKING SWEET TASTE ENHANCERS
The present invention includes methods/processes and intermediates for preparing compounds having structural Formula (XI):
##STR00001## wherein Y is C.sub.1-C.sub.12 alkylene or C.sub.1-C.sub.12 alkenylene; and R.sup.8 and R.sup.12 are independently C.sub.1-C.sub.12 alkyl.
Processes and intermediates for making sweet taste enhancers
The present invention includes methods/processes and intermediates for preparing sulfamoyl chloride: ##STR00001##
Processes and intermediates for making sweet taste enhancers
The present invention includes methods/processes and intermediates for preparing sulfamoyl chloride: ##STR00001##
Inhibitors of human immunodeficiency virus replication
- John A. Bender ,
- Robert G. Gentles ,
- Annapurna PENDRI ,
- Alan Xiangdong Wang ,
- Nicholas A. MEANWELL ,
- Brett R. Beno ,
- Robert A. Fridell ,
- Makonen Belema ,
- Van N. Nguyen ,
- Zhong Yang ,
- Gan Wang ,
- Selvakumar Kumaravel ,
- Srinivasan Thangathirupathy ,
- Rajesh Onkardas Bora ,
- Shilpa Maheshwarappa Holehatti ,
- Mallikarjuna Rao Mettu ,
- Manoranjan Panda
Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: ##STR00001##
Inhibitors of human immunodeficiency virus replication
- John A. Bender ,
- Robert G. Gentles ,
- Annapurna PENDRI ,
- Alan Xiangdong Wang ,
- Nicholas A. MEANWELL ,
- Brett R. Beno ,
- Robert A. Fridell ,
- Makonen Belema ,
- Van N. Nguyen ,
- Zhong Yang ,
- Gan Wang ,
- Selvakumar Kumaravel ,
- Srinivasan Thangathirupathy ,
- Rajesh Onkardas Bora ,
- Shilpa Maheshwarappa Holehatti ,
- Mallikarjuna Rao Mettu ,
- Manoranjan Panda
Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: ##STR00001##
PRODRUGS OF PHENOLIC TRPV1 AGONISTS
Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
PRODRUGS OF PHENOLIC TRPV1 AGONISTS
Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.